Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology
|
July 2, 2024
[Clinicopathological analysis of atypical endocervical cells in cervical cytology]
P P Zhong, C Tian, Y He, et al.
Neoplasma
|
March 15, 2018
Low expression of Cyfip1 may be a potential biomarker in nasopharyngeal carcinoma
X Shi, X Chen, W C Li, et al.
Genetics and Molecular Research : GMR
|
May 11, 2013
HNF1b is involved in prostate cancer risk via modulating androgenic hormone effects and coordination with other genes
Y L Hu, D Zhong, F Pang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
June 21, 2019
[The clinical reports on adrenal insufficiency of patients with advanced solid tumors accepting anti-PD-1 antibody, SHR-1210 therapy]
J L Tang, J Huang, X Wang, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
January 14, 2012
Oestradiol is a protective factor for non-alcoholic fatty liver disease in healthy men
G-X Tian, Y Sun, C-J Pang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
November 6, 2018
[Clinical observation of thyroid-related adverse events induced by anti-PD-1 antibody SHR-1210 in patients with advanced solid tumor]
L Qi, H N Mo, X L Chen, et al.
Clinical and Experimental Dermatology
|
October 26, 2017
Antioxidant status of serum bilirubin, uric acid and albumin in pemphigus vulgaris
W C Li, L J Mo, X Shi, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
April 21, 2022
[A real world study on the relationship between drug resistance of targeted therapy and prognosis of HER-2-positive advanced breast cancer]
Z J Wang, Y Q Han, Q Li, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
February 20, 2022
[Efficacy and survival outcomes of dose-dense carboplatin plus paclitaxel as neoadjuvant chemotherapy for triple-negative breast cancer]
Y Liu, M Xiu, X Wang, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology
|
July 2, 2024
[Clinicopathological analysis of atypical endocervical cells in cervical cytology]
P P Zhong, C Tian, Y He, et al.
Neoplasma
|
March 15, 2018
Low expression of Cyfip1 may be a potential biomarker in nasopharyngeal carcinoma
X Shi, X Chen, W C Li, et al.
Genetics and Molecular Research : GMR
|
May 11, 2013
HNF1b is involved in prostate cancer risk via modulating androgenic hormone effects and coordination with other genes
Y L Hu, D Zhong, F Pang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
June 21, 2019
[The clinical reports on adrenal insufficiency of patients with advanced solid tumors accepting anti-PD-1 antibody, SHR-1210 therapy]
J L Tang, J Huang, X Wang, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
January 14, 2012
Oestradiol is a protective factor for non-alcoholic fatty liver disease in healthy men
G-X Tian, Y Sun, C-J Pang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
November 6, 2018
[Clinical observation of thyroid-related adverse events induced by anti-PD-1 antibody SHR-1210 in patients with advanced solid tumor]
L Qi, H N Mo, X L Chen, et al.
Clinical and Experimental Dermatology
|
October 26, 2017
Antioxidant status of serum bilirubin, uric acid and albumin in pemphigus vulgaris
W C Li, L J Mo, X Shi, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
April 21, 2022
[A real world study on the relationship between drug resistance of targeted therapy and prognosis of HER-2-positive advanced breast cancer]
Z J Wang, Y Q Han, Q Li, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
February 20, 2022
[Efficacy and survival outcomes of dose-dense carboplatin plus paclitaxel as neoadjuvant chemotherapy for triple-negative breast cancer]
Y Liu, M Xiu, X Wang, et al.
Page
of 5